endocrine and exocrine dysfunction which results in decreased quality of life and reduced
life expectancy. 1 Adam et al recently published an interesting study on a possible
diagnostic tool for CP based on metabolomic profiles of patients and controls. 2 Our
previous international cohort analysis showed that the proportion of patients developing CP
is exponentially and directly associated with the number of acute pancreatitis (AP) episodes …